Pioneering Science for Patient Choice
Advancing new oral alternatives for all people living with hereditary angioedema (HAE)
View our SciencePharvaris aims to develop novel, oral alternatives that improve the standard of care for people living with HAE.
View our PipelineHAE CHAPTER-1
Oral prophylactic treatment study
RAPIDe-2
Extension study of oral on-demand treatment
Pharvaris is a leader in bradykinin-mediated diseases, aiming to deliver effective, safe and easy to administer therapies.
View our SciencePharvaris is committed to improving the treatment of HAE and the quality of life for people living with HAE.
HAE CommunityOur legacy in HAE, our scientific expertise, and our values drive our passion as we aspire to provide choice to people living with HAE.
About Us